DrugPatentWatch Database Preview
Glenmark Pharms Company Profile
What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?
GLENMARK PHARMS has seventy-nine approved drugs.
There are eight tentative approvals on GLENMARK PHARMS drugs.
Summary for Glenmark Pharms
| US Patents: | 0 |
| Tradenames: | 62 |
| Ingredients: | 58 |
| NDAs: | 79 |
Drugs and US Patents for Glenmark Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | FENOFIBRATE (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 205566-001 | Apr 7, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Glenmark Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209663-001 | Nov 15, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Glenmark Pharms | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 079172-001 | Jul 19, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Glenmark Pharms Ltd | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 090527-004 | May 27, 2009 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
